Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Gene Solutions a leading multinational biotechnology company and Shenzhen USK Bioscience Co Ltd USKBio a prominent innovator in molecular diagnostics have entered a strategic partnership through a Memorandum
Samsung Biologics a leading contract development and manufacturing organization CDMO today announced the launch of Samsung Organoids advanced drug screening services to support clients in drug discovery and development
Vascarta Inc a biopharmaceutical company committed to advancing innovative therapies for underserved patient populations announced today that the US Food and Drug Administration FDA has granted Orphan
Sumitomo Pharma America Inc SMPA today announced that the US Food and Drug Administration FDA granted Fast Track Designation to nuvisertib TP for the treatment of patients with intermediate
Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML a novel oral small molecule drug targeting earlystage Alzheimers disease AD TML combines multiple mechanisms
Mitsubishi Research Institute Inc MRI and Astellas Pharma Inc Astellas today announced that they have agreed on a memorandum of understanding to provide drugdiscovery startups in Japan
Simtra BioPharma Solutions a leading contract development and manufacturing organization CDMO specializing in sterile injectables today announced that it has formed a fiveyear strategic alliance
Deep Apple Therapeutics Inc announced today a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover develop and commercialize oral small molecule
Cytiva a Danaher company and global life sciences leader has completed significant expansion projects in several locations in the United States Europe and Asia as part of its ongoing commitment
Mesoblastglobal leader in allogeneic cellular medicines for inflammatory diseases today provided an update on continued momentum with United States Food and Drug Administration FDA regarding
